. "Vyt\u0159\u00EDsalov\u00E1, Magda" . "osteoporosis; database; pill counts; questionnaire; electronic monitoring; persistence; compliance; adherence"@en . . . "89792" . . . "CZ - \u010Cesk\u00E1 republika" . . "Vl\u010Dek, Ji\u0159\u00ED" . "Measures of adherence to therapy in patients with osteoporosis"@en . . . "Nedostate\u010Dn\u00E1 adherence k l\u00E9\u010Db\u011B je v\u0161eobecn\u00FDm probl\u00E9mem v terapii chronick\u00FDch onemocn\u011Bn\u00ED, zejm\u00E9na t\u011Bch s asymptomatick\u00FDm charakterem. Zp\u016Fsobem, jak toto riziko eliminovat nebo alespo\u0148 kontrolovat, je monitorov\u00E1n\u00ED adherence. K vlastn\u00EDmu m\u011B\u0159en\u00ED adherence jsou vyu\u017E\u00EDv\u00E1ny metody, kter\u00E9 hodnot\u00ED objektivn\u00ED \u010Di subjektivn\u00ED parametry pacientova p\u0159\u00EDstupu k l\u00E9\u010Debn\u00E9mu pl\u00E1nu. Adherence k l\u00E9\u010Db\u011B osteopor\u00F3zy je obvykle m\u011B\u0159ena pomoc\u00ED nep\u0159\u00EDm\u00FDch metod. Mezi nejjednodu\u0161\u0161\u00ED a v praxi snadno aplikovateln\u00E9 n\u00E1stroje pat\u0159\u00ED v\u00FDpov\u011Bdi pacienta v\u010Detn\u011B dotazn\u00EDkov\u00FDch \u0161et\u0159en\u00ED a po\u010D\u00EDt\u00E1n\u00ED tablet. Ob\u011B metody v\u0161ak zat\u011B\u017Euje v\u00FDznamn\u00E9 riziko nadhodnocen\u00ED adherence. P\u0159\u00EDslibem dal\u0161\u00EDho pokroku ve v\u00FDzkumu adherence u osteopor\u00F3zy jsou dotazn\u00EDky specificky zam\u011B\u0159en\u00E9 na toto metabolick\u00E9 onemocn\u011Bn\u00ED. Za referen\u010Dn\u00ED standard nep\u0159\u00EDm\u00FDch metod je nyn\u00ED \u010Dasto pova\u017Eov\u00E1no elektronick\u00E9 monitorov\u00E1n\u00ED. Zejm\u00E9na prost\u0159ednictv\u00EDm monitorovac\u00EDch za\u0159\u00EDzen\u00ED typu MEMS (Medication Event Monitoring System) je mo\u017En\u00E9 velmi p\u0159esn\u011B monitorovat adherenci k aktu\u00E1ln\u011B prob\u00EDhaj\u00EDc\u00ED terapii a sledovat konkr\u00E9tn\u00ED datum i \u010Das u\u017Eit\u00ED l\u00E9\u010Diva. S \u00FAsp\u011Bchem je toho vyu\u017E\u00EDv\u00E1no nap\u0159\u00EDklad u specifick\u00E9ho re\u017Eimu antiresorp\u010Dn\u00ED terapie osteopor\u00F3zy. Anal\u00FDzy z\u00E1znam\u016F o v\u00FDdeji l\u00E9\u010Div odr\u00E1\u017E\u00ED dlouhodob\u00E9 trendy l\u00E9\u010Dby chronick\u00FDch onemocn\u011Bn\u00ED a p\u0159in\u00E1\u0161\u00ED nejv\u011Brn\u011Bj\u0161\u00ED obr\u00E1zek o perzistenci. V p\u0159edkl\u00E1dan\u00E9m \u010Dl\u00E1nku jsou uveden\u00E9 nep\u0159\u00EDm\u00E9 metody podrobn\u011Bji pops\u00E1ny. D\u00E1le jsou diskutov\u00E1ny jejich v\u00FDhody a nev\u00FDhody a mo\u017Enosti vyu\u017Eit\u00ED v m\u011B\u0159en\u00ED adherence k l\u00E9\u010Db\u011B osteopor\u00F3zy." . "1" . "RIV/00216208:11160/13:10292137!RIV15-MSM-11160___" . . "18" . "1211-3778" . "RIV/00216208:11160/13:10292137" . . "Mo\u017Enosti m\u011B\u0159en\u00ED adherence k l\u00E9\u010Db\u011B u pacient\u016F s osteopor\u00F3zou" . "[351B7170042A]" . . "Poor adherence to the treatment is widespread problem in therapy of chronic diseases, particularly in asymptomatic conditions. Measuring of adherence is a way how to eliminate this risk or at least control it. There are several methods which can evaluate objective and subjective parameters of patient's approach to the treatment plan. Adherence to the therapy of osteoporosis is usually measured by indirect methods. Self-reports and pill counts belong to the simplest instruments, very easily applicable to the practice, but with high risk of overestimation of adherence. Promising progress in research of adherence to osteoporosis treatment seems to become specific questionnaires to this metabolic illness. As the reference standard of indirect methods is often considered electronic monitoring. Particularly the Medication Event Monitoring System can precisely monitor adherence to current therapy and observe certain date and time of drug administration. This takes advantage, for example, of specific dosage regime of antiresorptive therapy of osteoporosis. Prescription refill analysis reflects long-term trends of therapy of chronic diseases and carries accurate assessment of persistence. In this paper there are described mentioned indirect methods with their advantages and disadvantages and their options in measuring of adherence to the therapy of osteoporosis."@en . "6"^^ . "3"^^ . . "3"^^ . . "Osteologick\u00FD bulletin" . . . "Mo\u017Enosti m\u011B\u0159en\u00ED adherence k l\u00E9\u010Db\u011B u pacient\u016F s osteopor\u00F3zou" . . . "Mo\u017Enosti m\u011B\u0159en\u00ED adherence k l\u00E9\u010Db\u011B u pacient\u016F s osteopor\u00F3zou"@cs . . "Measures of adherence to therapy in patients with osteoporosis"@en . "Mo\u017Enosti m\u011B\u0159en\u00ED adherence k l\u00E9\u010Db\u011B u pacient\u016F s osteopor\u00F3zou"@cs . . "11160" . "Nedostate\u010Dn\u00E1 adherence k l\u00E9\u010Db\u011B je v\u0161eobecn\u00FDm probl\u00E9mem v terapii chronick\u00FDch onemocn\u011Bn\u00ED, zejm\u00E9na t\u011Bch s asymptomatick\u00FDm charakterem. Zp\u016Fsobem, jak toto riziko eliminovat nebo alespo\u0148 kontrolovat, je monitorov\u00E1n\u00ED adherence. K vlastn\u00EDmu m\u011B\u0159en\u00ED adherence jsou vyu\u017E\u00EDv\u00E1ny metody, kter\u00E9 hodnot\u00ED objektivn\u00ED \u010Di subjektivn\u00ED parametry pacientova p\u0159\u00EDstupu k l\u00E9\u010Debn\u00E9mu pl\u00E1nu. Adherence k l\u00E9\u010Db\u011B osteopor\u00F3zy je obvykle m\u011B\u0159ena pomoc\u00ED nep\u0159\u00EDm\u00FDch metod. Mezi nejjednodu\u0161\u0161\u00ED a v praxi snadno aplikovateln\u00E9 n\u00E1stroje pat\u0159\u00ED v\u00FDpov\u011Bdi pacienta v\u010Detn\u011B dotazn\u00EDkov\u00FDch \u0161et\u0159en\u00ED a po\u010D\u00EDt\u00E1n\u00ED tablet. Ob\u011B metody v\u0161ak zat\u011B\u017Euje v\u00FDznamn\u00E9 riziko nadhodnocen\u00ED adherence. P\u0159\u00EDslibem dal\u0161\u00EDho pokroku ve v\u00FDzkumu adherence u osteopor\u00F3zy jsou dotazn\u00EDky specificky zam\u011B\u0159en\u00E9 na toto metabolick\u00E9 onemocn\u011Bn\u00ED. Za referen\u010Dn\u00ED standard nep\u0159\u00EDm\u00FDch metod je nyn\u00ED \u010Dasto pova\u017Eov\u00E1no elektronick\u00E9 monitorov\u00E1n\u00ED. Zejm\u00E9na prost\u0159ednictv\u00EDm monitorovac\u00EDch za\u0159\u00EDzen\u00ED typu MEMS (Medication Event Monitoring System) je mo\u017En\u00E9 velmi p\u0159esn\u011B monitorovat adherenci k aktu\u00E1ln\u011B prob\u00EDhaj\u00EDc\u00ED terapii a sledovat konkr\u00E9tn\u00ED datum i \u010Das u\u017Eit\u00ED l\u00E9\u010Diva. S \u00FAsp\u011Bchem je toho vyu\u017E\u00EDv\u00E1no nap\u0159\u00EDklad u specifick\u00E9ho re\u017Eimu antiresorp\u010Dn\u00ED terapie osteopor\u00F3zy. Anal\u00FDzy z\u00E1znam\u016F o v\u00FDdeji l\u00E9\u010Div odr\u00E1\u017E\u00ED dlouhodob\u00E9 trendy l\u00E9\u010Dby chronick\u00FDch onemocn\u011Bn\u00ED a p\u0159in\u00E1\u0161\u00ED nejv\u011Brn\u011Bj\u0161\u00ED obr\u00E1zek o perzistenci. V p\u0159edkl\u00E1dan\u00E9m \u010Dl\u00E1nku jsou uveden\u00E9 nep\u0159\u00EDm\u00E9 metody podrobn\u011Bji pops\u00E1ny. D\u00E1le jsou diskutov\u00E1ny jejich v\u00FDhody a nev\u00FDhody a mo\u017Enosti vyu\u017Eit\u00ED v m\u011B\u0159en\u00ED adherence k l\u00E9\u010Db\u011B osteopor\u00F3zy."@cs . "L\u00E1dov\u00E1, Kate\u0159ina" . . . "I, S" . .